'Super tree' maps 20,000 medicinal, related plants

September 11, 2012
'Super tree' maps 20,000 medicinal, related plants

(Medical Xpress)—New research from the University of Reading, The Royal Botanic Gardens, Kew and Imperial College London published on 10 September in the Proceedings of the National Academy of Sciences (PNAS) could allow biopharmaceutical companies to distinguish groups of plants most likely to be beneficial to our health.

Throughout history have been used for their medicinal properties.  According to the approximately 25% of medicines are plant-derived and many are derived from plants that were first used in traditional systems of medicine, including drugs used in the treatment of and heart disease.

As are decimated by changing land use, and over exploitation, identifying the species most likely to contribute to needs could hardly be more urgent or significant. But with tens of thousands of species used by different cultures, identifying those likely to be of benefit is a time consuming and expensive process.

By studying and recording over 1,500 medicinal plants reported to have in three continents, the researchers created a family tree of for each area, demonstrating how medicinal plants relate to each other. They then combined the trees to create a 'super' family tree representing 20,000 species to reveal which medicinal plants from different areas were related.

The results were extraordinary. Not only did the researchers find examples of very closely related plants being used as medicines in different parts of the world, they also discovered they were being used to treat the same ailments. Furthermore, they found that many modern day drugs come from these groups of closely related plants.

This study, the first of its kind, could enhance the success rate of companies involved in bio-prospecting, the search for new, economically-valuable biological products.  Plants have a vital role to play medically. Paclitaxel, which is used as a treatment for breast cancer, derives from yew trees, while foxgloves contain a key ingredient used in cardiotonics which treat heart failure.

Dr Julie Hawkins, from the School of Biological Sciences at the University of Reading, said: "Our study examined plants known to be used medicinally in Nepal, New Zealand and the Cape of South Africa, areas unlikely to have exchanged information about medicinal properties of plants so would be using these plants after discovering them independently. We found that plants known to be useful in all three separate regions were from groups that were closely related.

"Across the whole of the super tree we found many groups of related plants that had been independently discovered. One example is that plants from the soapberry family are used in Nepal, the Cape of South Africa and New Zealand to treat gastro-intestinal problems. It seems these treatments, using closely related plants, have been independently discovered. Additionally, the study showed that other closely related plants that are not used by traditional medicine in these regions, such as maple or lychee trees, could also have medicinal properties.

"Our super tree will help companies involved in bioprospecting narrow their search for plants with medicinal properties which could lead to new disease fighting drugs." continued Dr Hawkins. "It's incredibly exciting to think that communities around the world that weren't in contact with each other have sampled related plants and are using them to treat the same things."

Co-author of the study, Professor Vincent Savolainen from the Department of Life Sciences at Imperial College London, and RBG Kew, said: "This super family tree of medicinal plants will help create new opportunities to make modern medicines from the active ingredients in traditional medical treatments. I strongly urge biomedical scientists to use our study to speed up their search for innovative new medicines, but in doing so they have to fulfil a duty to the people who discovered the beneficial effects of such traditional medicines.

"Many have signed up to the International Convention on Biological Diversity, which requires individuals and companies to acknowledge the origins of their discoveries. Now, more should be done to follow this through, for example by sharing the financial benefits of a commercialised drug, or involving traditional practitioners in the development of modern medical treatments in their countries of origin."

Dr Haris Saslis-Lagoudakis, who contributed to this research as part of his PhD thesis, said: "Traditional medicine has been neglected in recent years in research on the discovery of new medicinal plants and pharmaceutical drugs. It is fascinating to demonstrate that traditional knowledge that has been compiled through centuries by local communities around the globe could hold the key to curing modern-day diseases."

Explore further: Plants may be key to diabetes treatment

More information: "Phylogenies reveal predictive power of traditional medicine in bioprospecting," by C. Harris Saslis-Lagoudakis et al. PNAS, 2012.

Related Stories

Plants may be key to diabetes treatment

June 29, 2012
(Medical Xpress) -- With the growing worldwide incidence of diabetes, a new study reveals that traditional Aboriginal and Indian plant extracts show potential for managing the disease.

Herbal abortion helps African women

August 26, 2011
Researchers at the Faculty of Pharmaceutical Sciences, University of Copenhagen, have examined a number of plants which are used for illegal abortions in Tanzania. The lab tests show that several of the plants can make the ...

Recommended for you

Drug for spinal muscular atrophy prompts ethical dilemmas, bioethicists say

December 11, 2017
When the Food and Drug Administration approved the first drug for people with spinal muscular atrophy a year ago, clinicians finally had hope for improving the lives of patients with the rare debilitating muscular disease. ...

FDA's program to speed up drug approval shaved nearly a year off the process

December 7, 2017
Speeding the pace at which potentially lifesaving drugs are brought to market was a rallying cry for Donald Trump as a candidate, and is a stated priority of his Food and Drug Administration commissioner, Dr. Scott Gottlieb. ...

Dangers of commonly prescribed painkillers highlighted in study

December 6, 2017
Commonly prescribed painkillers need to be given for shorter periods of time to reduce the risk of obesity and sleep deprivation, a new study has revealed.

Viagra goes generic: Pfizer to launch own little white pill

December 6, 2017
The little blue pill that's helped millions of men in the bedroom is turning white. Drugmaker Pfizer is launching its own cheaper generic version of Viagra rather than lose most sales when the impotence pill gets its first ...

Surgery-related opioid doses can drop dramatically without affecting patients' pain

December 6, 2017
Some surgeons might be able to prescribe a third of opioid painkiller pills that they currently give patients, and not affect their level of post-surgery pain control, a new study suggests.

Four-fold jump in deaths in opioid-driven hospitalizations

December 4, 2017
People who end up in the hospital due to an opioid-related condition are four times more likely to die now than they were in 2000, according to research led by Harvard Medical School and published in the December issue of ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.